Healthcare scheduling platforms fall within Digital Health & Telemedicine's 4–6x Revenue range, with provider/practice client retention and depth of EHR/practice-management integrations the biggest value drivers. A platform with deep integrations and long-tenured practice clients typically prices higher than one that's easily swapped out.
Buyers evaluating a healthcare scheduling platform acquisition typically dig into:
Healthcare Scheduling Platforms are valued within the broader Digital Health & Telemedicine range. Your client retention, EHR integration depth, and recurring revenue model determine where you land.
Healthcare scheduling platforms draw interest from larger healthcare technology and EHR companies seeking to add scheduling capability, private equity firms building digital health software platforms, and strategic buyers such as practice management companies. Digital health and telemedicine is growing at roughly 19.7% annually, with the market expanding from an estimated $427 billion in 2025 toward a projected $1.5 trillion by 2032, and private equity has been actively investing across the category.
Yes, significantly — the deeper and more numerous your integrations with major EHR and practice management systems, the harder your platform is for a client to replace, which is a meaningful competitive moat.
Very important — software that's woven into a practice's daily workflow tends to have low churn, and a demonstrated track record of long client tenure is one of the clearest signs of a sticky, valuable platform.
Yes — features that demonstrably reduce no-shows translate directly into revenue for your healthcare clients, which makes the platform easier to sell and retain, and is worth quantifying for a buyer.
Yes — it's part of the broader digital health technology market, which continues to see strong investment as practices and health systems digitize more of their patient-facing operations.
Not quite the right fit? Here are the other business types Forefront works with in this category.